LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 46 filers reported holding LARIMAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,457,125 | +34.7% | 2,900,538 | +6.8% | 0.13% | +18.6% |
| Q2 2023 | $8,503,312 | -3.2% | 2,716,713 | +40.1% | 0.11% | -7.4% |
| Q1 2023 | $8,782,864 | +44.1% | 1,938,822 | +31.3% | 0.12% | +28.4% |
| Q4 2022 | $6,096,805 | +36.8% | 1,476,224 | -46.9% | 0.10% | +90.0% |
| Q3 2022 | $4,456,452 | +462.7% | 2,782,672 | +589.0% | 0.05% | +212.5% |
| Q2 2022 | $792,000 | -54.0% | 403,890 | -4.9% | 0.02% | -23.8% |
| Q1 2022 | $1,720,000 | -32.4% | 424,599 | +80.0% | 0.02% | +16.7% |
| Q4 2021 | $2,545,000 | +177.2% | 235,835 | +196.1% | 0.02% | +125.0% |
| Q3 2021 | $918,000 | -61.8% | 79,656 | -67.4% | 0.01% | -63.6% |
| Q2 2021 | $2,403,000 | -28.3% | 244,675 | +6.7% | 0.02% | -42.1% |
| Q1 2021 | $3,350,000 | +27.1% | 229,301 | +86.3% | 0.04% | +65.2% |
| Q4 2020 | $2,636,000 | +234.1% | 123,107 | +136.7% | 0.02% | +43.8% |
| Q3 2020 | $789,000 | – | 52,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,515,148 | $2,970,000 | 1.13% |
| Opaleye Management Inc. | 932,814 | $1,828,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,830,249 | $11,427,000 | 0.24% |
| Fi3 FINANCIAL ADVISORS, LLC | 121,818 | $239,000 | 0.20% |
| Atlas Venture Advisors, Inc. | 292,184 | $573,000 | 0.18% |
| MANGROVE PARTNERS IM, LLC | 867,812 | $1,701,000 | 0.08% |
| RA Capital Management | 1,031,482 | $2,022,000 | 0.05% |
| DIFESA CAPITAL MANAGEMENT, LP | 34,550 | $68,000 | 0.04% |
| 683 Capital Management, LLC | 248,800 | $488,000 | 0.03% |
| DAFNA Capital Management LLC | 49,996 | $98,000 | 0.03% |